Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Javle

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 3, 2004
Should preoperative, post-chemoradiotherapy endoscopy be routine for esophageal cancer patients?A Shaukat, A Mortazavi, T Demmy, et al.
Hepato-Gastroenterology|November 10, 2004
Nuclear survivin expression predicts poor outcome in cholangiocarcinomaMilind M Javle, Dongfeng Tan, Jihnhee Yu, et al.
Journal of Gastrointestinal Oncology|December 2, 2014
Second-line systemic treatment for advanced cholangiocarcinomaJane E Rogers, Lindsey Law, Van D Nguyen, et al.
British Journal of Cancer|June 4, 2009
Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II studyM Javle, J Yu, C Garrett, et al.
Annals of Surgical Oncology|August 21, 2007
A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: a single-institution prospective studyRenuka V Iyer, John Gibbs, Boris Kuvshinoff, et al.
The Journal of Supportive Oncology|October 20, 2007
Malignant gastroparesis: pathogenesis and management of an underrecognized disorderKavitha R Donthireddy, Sikander Ailawadhi, Eiad Nasser, et al.
ESMO Open|December 18, 2021
Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp)M M Javle, D-Y Oh, M Ikeda, et al.
British Journal of Cancer|March 6, 2015
Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancerM Zuo, A Rashid, C Churi, et al.
The British Journal of Surgery|January 5, 2017
Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancerS Yamashita, G Passot, T A Aloia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Unusual locations of involvement by malignancies: Case 3. Gastric signet ring carcinoma presenting as a diffuse thigh massGeetha N Varma, Janet S Winston, Hank C Hill, et al.
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 3, 2004
Should preoperative, post-chemoradiotherapy endoscopy be routine for esophageal cancer patients?A Shaukat, A Mortazavi, T Demmy, et al.
Hepato-Gastroenterology|November 10, 2004
Nuclear survivin expression predicts poor outcome in cholangiocarcinomaMilind M Javle, Dongfeng Tan, Jihnhee Yu, et al.
Journal of Gastrointestinal Oncology|December 2, 2014
Second-line systemic treatment for advanced cholangiocarcinomaJane E Rogers, Lindsey Law, Van D Nguyen, et al.
British Journal of Cancer|June 4, 2009
Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II studyM Javle, J Yu, C Garrett, et al.
Annals of Surgical Oncology|August 21, 2007
A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: a single-institution prospective studyRenuka V Iyer, John Gibbs, Boris Kuvshinoff, et al.
The Journal of Supportive Oncology|October 20, 2007
Malignant gastroparesis: pathogenesis and management of an underrecognized disorderKavitha R Donthireddy, Sikander Ailawadhi, Eiad Nasser, et al.
ESMO Open|December 18, 2021
Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp)M M Javle, D-Y Oh, M Ikeda, et al.
British Journal of Cancer|March 6, 2015
Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancerM Zuo, A Rashid, C Churi, et al.
The British Journal of Surgery|January 5, 2017
Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancerS Yamashita, G Passot, T A Aloia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2003
Unusual locations of involvement by malignancies: Case 3. Gastric signet ring carcinoma presenting as a diffuse thigh massGeetha N Varma, Janet S Winston, Hank C Hill, et al.
Pageof 10